Envestnet Portfolio Solutions’s GSK GSK Stock Holding History

Envestnet Portfolio Solutions’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$951K	Buy	18,135 +585	+3%	+$30.9K	﹤0.01%	733
2026 Q1	$969K	Sell	17,550 -46,844	-73%	-$2.54M	0.01%	644
2025 Q4	$3.16M	Sell	64,394 -6,735	-9%	-$314K	0.01%	455
2025 Q3	$3.07M	Buy	71,129 +663	+0.9%	+$25.9K	0.01%	439
2025 Q2	$2.71M	Buy	70,466 +54,406	+339%	+$2.08M	0.01%	486
2025 Q1	$622K	Sell	16,060 -28,957	-64%	-$1.06M	﹤0.01%	963
2024 Q4	$1.52M	Sell	45,017 -7,125	-14%	-$256K	0.01%	766
2024 Q3	$2.13M	Buy	52,142 +4,130	+9%	+$169K	0.01%	641
2024 Q2	$1.85M	Sell	48,012 -12	-0%	-$505	0.01%	658
2024 Q1	$2.06M	Sell	48,024 -8,608	-15%	-$355K	0.01%	627
2023 Q4	$2.1M	Buy	56,632 +7,943	+16%	+$285K	0.01%	583
2023 Q3	$1.76M	Buy	+48,689	New	+$1.73M	0.01%	576

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Envestnet Portfolio Solutions's GSK Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its GSK (GSK) stake by 3.3% in Q2 2026, buying an estimated $30.9K and bringing the position to 18,135 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Envestnet Portfolio Solutions first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.16M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Envestnet Portfolio Solutions held 18,135 shares of GSK worth $951K as of Q2 2026.
Envestnet Portfolio Solutions bought 585 GSK shares in Q2 2026, an estimated $30.9K.
GSK made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #733 holding.
Envestnet Portfolio Solutions first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
Envestnet Portfolio Solutions's GSK position peaked at $3.16M in Q4 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.